An Expanded Access Study of Brigatinib for Patients With ALK-positive Advanced Non-Small Cell Lung Cancer
about
An Expanded Access Study of Brigatinib for Patients With ALK-positive Advanced Non-Small Cell Lung Cancer
description
clinical trial
@en
klinisch onderzoek
@nl
name
An Expanded Access Study of Br ...... ced Non-Small Cell Lung Cancer
@en
type
label
An Expanded Access Study of Br ...... ced Non-Small Cell Lung Cancer
@en
prefLabel
An Expanded Access Study of Br ...... ced Non-Small Cell Lung Cancer
@en
P1050
P3098
NCT02784158